Third Generation CAR T Cell Study Supports Use Of BioOra's Automated Manufacture For Phase 2 Trial
BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego.
San Diego United States New Zealand Rob Weinkove Malaghan Institute Clinical American Society Of Hematology
Source: scoop.co.nz